Literature DB >> 2383745

Changing patterns of incidence and mortality from acute pancreatitis in Scotland, 1961-1985.

C Wilson1, C W Imrie.   

Abstract

Data on all discharges from hospitals in Scotland have been recorded since 1961 as the Scottish Hospital In-Patient Statistics and examination of these data has permitted analysis of the incidence and mortality trends from acute pancreatitis. The number of discharges recorded has increased 11-fold in males from 69 patients/year in 1961 to 750 patients/year in 1985, and fourfold in females from 112 patients/year to 484 patients/year respectively. This increase has occurred particularly amongst young and middle-aged males (20-59 years) and in elderly females (over 60 years), the most marked increases occurring in the health boards of the 'central belt' area of Scotland. Mortality rate did not show a corresponding change, increasing only two-fold in males from 15 patients/year to 30 patients/year and in females from 29 patients/year to 37 patients/year. As a consequence the case mortality rate has fallen from 17.8 per cent over the period 1961-65 to 5.6 per cent over the period 1981-85. An apparent increase in the incidence of acute pancreatitis may be inferred from these data, much of which is thought to be due to improved accuracy in diagnosis.

Entities:  

Mesh:

Year:  1990        PMID: 2383745     DOI: 10.1002/bjs.1800770705

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  27 in total

1.  A useful mnemonic for severity stratification in acute pancreatitis.

Authors:  E M Moore
Journal:  Ann R Coll Surg Engl       Date:  2000-01       Impact factor: 1.891

2.  Implementation of a novel emergency surgical unit significantly improves the management of gallstone pancreatitis.

Authors:  S Bokhari; M Kulendran; L Liasis; K Qurashi; M Sen; S Gould
Journal:  Ann R Coll Surg Engl       Date:  2015-05       Impact factor: 1.891

Review 3.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

4.  Acute pancreatitis--from cellular signalling to complicated clinical course.

Authors:  Roland Andersson; Bodil Andersson; Ellen Andersson; Jakob Axelsson; Gunilla Eckerwall; Bobby Tingstedt
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 5.  Management of necrotizing pancreatitis.

Authors:  J Slavin; P Ghaneh; R Sutton; M Hartley; P Rowlands; C Garvey; M Hughes; J Neoptolemos
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

6.  A prospective audit against national standards of the presentation and management of acute pancreatitis in the South of England.

Authors:  S K Toh; S Phillips; C D Johnson
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

Review 7.  The clinical problem of biliary acute necrotizing pancreatitis: epidemiology, pathophysiology, and diagnosis of biliary necrotizing pancreatitis.

Authors:  C E Forsmark
Journal:  J Gastrointest Surg       Date:  2001 May-Jun       Impact factor: 3.452

8.  Extrapancreatic organ impairment during acute pancreatitis induced by bile-pancreatic duct obstruction. Effect of N-acetylcysteine.

Authors:  Manuel A Manso; Laura Ramudo; Isabel De Dios
Journal:  Int J Exp Pathol       Date:  2007-10       Impact factor: 1.925

9.  Pancreatitis in Finland between 1970 and 1989.

Authors:  M Jaakkola; I Nordback
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

10.  Kallikrein inhibitors limit kinin B(2) antagonist-induced progression of oedematous to haemorrhagic pancreatitis in rats.

Authors:  T Griesbacher; I Rainer; B Tiran; B A Peskar
Journal:  Br J Pharmacol       Date:  2008-08-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.